Was a Drop in CRISPR Firms’ Stock Warranted? – The Scientist
The Scientist |
Was a Drop in CRISPR Firms’ Stock Warranted?
The Scientist ISTOCK, VCHALLast week, a study made headlines worldwide with its claim that the CRISPR-Cas9 genome-editing technique is more error prone than expected. In response, some investors chose to sell their shares in CRISPR-based biotech firms and stock … Someday, MaybeGenomeWeb |
News-Medical.net |
Researchers find long-lasting benefits of gene therapy in dog model of myotubular myopathy
News-Medical.net Researchers who previously showed that a gene therapy treatment could save the lives of dogs with a deadly disease called myotubular myopathy—a type of muscular dystrophy that affects the skeletal muscles—have found that the therapy is long-lasting. |